Extreme Prostate‐Specific Antigen Response to Infusional 5‐Flourouracil in Castrate‐Resistant Prostate Cancer

Prostate cancer that has progressed after androgen deprivation, abiraterone, and taxane therapy is challenging to treat successfully. Herein we report a dramatic response to continuous‐infusion 5‐fluorouracil (5‐FU) at a dose of 200 mg/m(2) in a patient with rapidly progressive, heavily pretreated,...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncologist
Hlavní autoři: Manogue, Charlotte, Ledet, Elisa, Guddati, A. Kumar, Lewis, Brian, Sartor, Oliver
Médium: Artigo
Jazyk:Inglês
Vydáno: AlphaMed Press 2017
Témata:
Brief Communications
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5905692/
https://ncbi.nlm.nih.gov/pubmed/29259071
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0450
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky